phenyl propanamine derivative (Xenon Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namephenyl propanamine derivative (Xenon Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor modulatorsSerotonin transporter modulators
TargetsSerotonin (5-HT) receptorSerotonin transporter
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEpilepsies, Myoclonic

Other Information

ATC CodeN/A
Related LinksN/A